← Leaderboards
Harold C Wiesenfeld
Magee-Women'S Res Inst And Foundation
$9,086,469
Attributed
$9,086,469
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$9,086,469 · 8
By mechanism
U19$6,453,680 · 4
R01$2,570,723 · 1
M01$62,066 · 3
Top collaborators
No co-investigators on record.
Most similar at Magee-Women'S Res Inst And Foundation
Same institution · by research overlap
- Ronald J Buckanovich$14,686,030
- Thomas L. Cherpes$9,554,133
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanAntibiotic TherapyAcuteAntibioticsGenital SystemInfectionRandomizedSexually Transmitted DiseasesProspectiveTreatment TrialClinical TrialsReproductive HealthFertilityTreatment ProtocolsStructureOrganismPelvic Inflammatory DiseaseEndometrialFollow-UpVaginaChlamydia TrachomatisReproductiveClinical ResearchHuman Subject
Grant awards (21)
Clinical Core$730,630
U19 · FY2013 · AI · contact PI
Clinical Core$431,119
U19 · FY2013 · AI · contact PI
Importance of Anti-Anaerobic Therapy for Acute PID$329,821
U19 · FY2013 · AI · contact PI
Importance of Anti-Anaerobic Therapy for Acute PID$127,579
U19 · FY2013 · AI · contact PI
Clinical Core$1,098,170
U19 · FY2012 · AI · contact PI
Importance of Anti-Anaerobic Therapy for Acute PID$214,957
U19 · FY2012 · AI · contact PI
Clinical Core$922,186
U19 · FY2011 · AI · contact PI
Importance of Anti-Anaerobic Therapy for Acute PID$340,044
U19 · FY2011 · AI · contact PI
Clinical Core$831,035
U19 · FY2010 · AI · contact PI
Importance of Anti-Anaerobic Therapy for Acute PID$306,835
U19 · FY2010 · AI · contact PI
Clinical Core$817,754
U19 · FY2009 · AI · contact PI
Importance of Anti-Anaerobic Therapy for Acute PID$303,550
U19 · FY2009 · AI · contact PI
Prevention of Infertility in Women With Subclinical PID$543,146
R01 · FY2007 · AI · contact PI
Prevention of Infertility in Women With Subclinical PID$577,772
R01 · FY2006 · AI · contact PI
Prevention of Infertility in Women With Subclinical PID$598,343
R01 · FY2005 · AI
PREVENTION OF INFERTILITY IN WOMEN WITH SUBCLINICAL PID$36,308
M01 · FY2005 · RR
INITIAL SAFETY OF CUR-BC10 IN NORMAL WOMEN$13,657
M01 · FY2005 · RR
ASSESSMENT OF CLINICAL PERFORMANCE OF SYSCAN3 ELISA AND CANDIA5$5,996
M01 · FY2005 · RR
Prevention of Infertility in Women With Subclinical PID$584,399
R01 · FY2004 · AI
Prevention of Infertility in Women with Subclinical PID$6,105
M01 · FY2004 · RR
Prevention of Infertility in Women With Subclinical PID$267,063
R01 · FY2003 · AI